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Introduction 
 
Cannabis has a long history of medicinal use, dating 
back thousands of years (1). However, with the 
discovery of morphine, hypodermic needles and other 
fast acting synthetic opioids in the ninetieth and the 
turn of the twentieth century- cannabis use declined as 
a medication(2). 
For most of the past six decades, cannabis has 
been considered a recreational drug, and was 
considered illegal in many jurisdictions. Yet in the 
past few years its association with medicine has made 
a dramatic comeback. As illustrated in figure 1, over 
the past six years (2010-2016) the terms “medical 
cannabis” and “medical marijuana” has seen a  
4- to 5-fold increase in references based on a 
historical trend analysis of the terms noted in the 
PubMed database. It would appear that the term 
medical cannabis is most often used over medical 
marijuana, in the emerging literature. 
In the past several years, claims on the potential 
for cannabis to treat, cure and prevent a number of 
diseases and conditions has led some to query 
whether these claims are overstated.  
A game changer for medical cannabis has been 
the ability to consume it without a need to actually 
inhale it along with other negative products of 
combustion. Newer technologies that allow for the 
vaporization of the full plant has made it less of a 
health concern (3). 
Noticeably the evidence on medical cannabis is 
lacking in both quality and quantity. To date most of 
the research has been conducted in Israel, however, 
with cannabis set to be legalized for use in Canada (4) 
and in a recent move in the United States, by the 
Obama administration (5), to remove barriers should 
allow researchers greater access to medical cannabis 
for testing in well-designed clinical trials.  
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Figure 1. Number of article titles using the terms: medical cannabis and medical marijuana in PubMed. 
In Canada, the federal marijuana regulations were 
updated in the summer of 2016 with the introduction 
of the Access to Cannabis for Medical Purposes 
Regulations (ACMPR). The aim of this newly 
update regulation (ACMPR) is to treat marijuana like 
other psychoactive drugs used for medical purposes. 
Many of the Colleges (eight provincial) in Canada 
prohibit or at best strongly discourage its members 
from dispensing, providing or accepting delivery of 
marijuana for medical purposes (6). Of major concern 
for most Colleges has been a lack of good evidence 
on both medical risks and therapeutic benefits of 
marijuana- intimating that physicians’ currently 
prescribing cannabis may be falling short of a fulsome 
informed consent process. 
The typical recommendation for Canadian 
physicians is that medical cannabis should not be a 
first line therapy and that documentation should 
outline that conventional therapies were attempted but 
were not successful (6). The legal defense 
organization for physicians practicing in Canada- the 
Canadian Medical Protective Association (CMPA), 
updated its guidance document following the passing 
of ACMPR regulations- a cursory read through this 
document quickly identifies a less than positive 
endorsement for physicians, highlighting mainly 
potential risks and limitations to physicians 
potentially interested in adding medical cannabis to 
their treatment recommendations. 
As the medical community has been slow to start- 
noticeable in the grey literature is the proliferation of 
website by patient and advocacy groups making 
claims that cannabis has the potential to treat ailments 
and symptoms ranging from AIDS related illness, 
Asperger’s, Bulimia, carpal tunnel syndrome to 
whiplash- making the differentiation between the 
miraculous and mere hype all the more challenging to 
identify (7-9). 
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